Investigation conclusion: it is indicated that the product is not returning for evaluation.Additionally, a lot number of the test strip product was not provided and neither manufacturing record review nor testing on reserve sample from the same lot could not be performed.Further investigation is not possible at this time.Alere has withdrawn the alere inratio®/inratio®2 pt/inr system from the market and is no longer manufacturing alere inratio® test strips and monitors.In addition, all alere inratio® test strips are now expired.Customers have been advised to work with their healthcare provider to transition to an alternative monitoring method, such as a plasma-based laboratory inr method or a point-of-care monitoring system from a different manufacturer.
|
Information was received regarding the death of a patient due to hemorrhage.Information alleged the involvement of an inratio system.However, no deficiency was specified and no additional information provided.Information alleged the involvement of an inratio system.However, no product deficiency was specified.There is insufficient evidence to reasonably suggest a device malfunction occurred.Furthermore, although there is no information directly linking the patient's death to use of the inratio system, this mdr is being conservatively filed as a hemorrhage is a potential coagulation-related event.
|